⌘K

Login Start Free

Home/Filings/4/0001214659-15-000047

4//SEC Filing

Anthera Pharmaceuticals Inc 4

Accession 0001214659-15-000047

CIK 0001316175operating

View on SEC.gov Company Profile

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 6:36 PM ET

Size

5.4 KB

Accession

0001214659-15-000047

Insider Transaction Report

Form 4

Period: 2014-12-30

Anthera Pharmaceuticals IncANTH

Director

Transactions

Award
Stock option (right to buy)
2014-12-30+12,500→ 12,500 total
Exercise: $1.61Exp: 2024-12-30→ Common Stock (12,500 underlying)

Footnotes (1)

[F1]The stock option vests and becomes exercisable in 12 equal monthly installments from the grant date of December 30, 2014. This stock option is fully exercisable on December 30, 2015.

Documents

1 file

4
marketforms-28292.xmlPrimary
PRIMARY DOCUMENT

Issuer

Anthera Pharmaceuticals Inc

CIK 0001316175

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001316175

Filing Metadata

Form type: 4
Filed: Jan 1, 7:00 PM ET
Accepted: Jan 2, 6:36 PM ET
Size: 5.4 KB

View on SEC.gov